Regulatory molecules for coronary expressions of VEGF and its angiogenic receptor KDR in hypoestrogenic middle-aged female rats

Molecular and Cellular Biochemistry

Volumn 259, Issue 1-2, 2004, Pages 189-196

  Jesmin, Subrina ^a   Sakuma, Ichiro ^a   Hattori, Yuichi ^a   Kitabatake, Akira ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary vessels; Endothelial nitric oxide synthese; Estrogen; Hypoxia inducible factor 1 ; Ovariectomy; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY BLOOD VESSEL; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION; GROUPS BY AGE; GROUPS BY SEX; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PROTEIN EXPRESSION; RAT;

AGE FACTORS; ANIMALS; CORONARY VESSELS; ESTRADIOL; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; OVARIECTOMY; RATS; RATS, INBRED WF; SEX FACTORS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

ANIMALIA;

EID: 1942474482     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000021372.99727.b3     Document Type: Article

References (37)

1. Van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans JC, Banga JD: Age at menopause as a risk factor for cardiovascular mortality. Lancet 347: 714-718, 1996
2. Phillips GB, Pinkernell BH, Jing TY: Relationship between serum sex hormones and coronary disease in postmenopausal women. Arterioscler Thromb Vasc Biol 17: 695-701, 1997
3. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-613, 1998
4. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D: Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343: 522-529, 2000
5. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016-1037, 1192
6. Barret-Connor E, Grady D: Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 19: 55-72. 1998
7. Grodstein F, Stampfer MJ: The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 38: 199-210, 1995
8. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikal V, Sacks FM: Effects of postmenopausal estrogen replacement on the concentration and metabolism of plasma lipoproteins. N Engl J Med 325: 1196-1204, 1991
9. Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273: 199-208, 1995
10. Bush TL, Barret-Conner E, Cowan LD, Criqui ML Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM: Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study. Circulation 75: 1102-1109, 1987
11. Losordo DW, Isner JM: Estrogen and angiogenesis. A review. Arterioscler Thromb Vasc Biol 21: 6-12, 2001
12. Jesmin S, Sakuma I, Hattori Y, Kitabatake A: In vivo estrogen manipulations on coronary capillary network and angiogenic molecule expression in middle-aged female rats. Arterioscler Thromb Vasc Biol 22: 1591-1597, 2002
13. Arnal JF, Clamens S, Pechet C, Negre-Salvayre A, Allera C, Girolami JP, Salvayre R, Bayard F: Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA 93: 4108-4113, 1996
14. Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO III: The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 96: 2795-2801, 1997
15. Hayashi T, Yamada K, Esaki T, Kazuya M, Satake S, Ishikawa T, Hidaka H, Iguchi A: Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 214: 847-855, 1995
16. McNeill AM, Kim N, Duckles SP, Krause DN, Kontos HA: Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30: 2186-2190, 1999
17. Yang S, Bae L, Zhang L: Estrogen increases eNOS and NOx release in human coronary artery endothelium. J Cardiovasc Pharmacol 36: 242-247, 2000
18. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC: Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 2567-2578, 1998
19. Klagsbrun M, D'Amore PA: Regulators of angiogenesis. Annu Rev Physiol 53: 217-239, 1991
20. Berra E, Milanini J, Richard DE, Le Gall M, Viñals F, Gothié E, Roux D, Pagès G, Pouysségur J: Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem Pharmacol 60: 1171-1178, 2000
21. Liu M-Y, Hattori Y, Fukao M, Sato A, Sakuma I, Kanno M: Alterations in EDHF-mediated hyperpolarization and relaxation in mesenteric arteries of female rats in long-term deficiency of oestrogen and during oestrus cycle. Br J Pharmacol 132: 1035-1046, 2001
22. Sakuma I, Liu M-Y, Sato A, Hayashi T, Iguchi A, Kitabatake A, Hattori Y: Endothelium-dependent hyperpolarization and relaxation in mesenteric arteries of middle-aged rats: Influence of oestrogen. Br J Pharmacol 135: 48-54, 2002
23. Mowa CN, Iwanaga T: Differential distribution of oestrogen receptor-α and -β mRNAs in the female reproductive organ of rats as revealed by in situ hybridization. J Endocrinol 165: 59-66, 2000
24. Jesmin S, Sakuma I, Hattori Y, Fujii S, Kitabatake A: Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodeling in a Type II diabetic rat model. Diabetologia 45: 402-415, 2002
25. Ferrara N: Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol 280: C1358-C1366, 2001
26. Mueller MD, Vigne J-L, Minchenko A, Lebovic DI, Leitman DC, Taylor RN: Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptor α and β. Proc Natl Acad Sci USA 97: 10972-10977, 2000
27. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995
28. Wenger RH, Gassmann M: Oxygen(es) and hypoxia-inducible factor-1 Biol Chem 378: 609-616, 1997
29. Wenger RH, Kvietikova I, Rolfs A, Gassmann M: Hypoxia-inducible factor-1α is regulated at the post-mRNA levels. Kidney Int 51: 560-563, 1997
30. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-40613, 1996
31. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98: 2018-2026, 1997
32. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM: Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578, 1998
33. Shizukuda Y, Tang S, Yokota R, Ware JA: Vascular endothelial growth factor-induced endothelial cell migration and proliferation depend on a nitric oxide-mediated decrease in protein kinase C delta activity. Circ Res 85: 247-256, 1999
34. Murohara T, Witzenbichler B, Spyridopoulos I, Asahara T, Ding B, Sullivan A, Losordo DW, Isner JM: Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Res 19: 1156-1161, 1999
35. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T: Upregulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 360: 291-293, 1995
36. Kroll J, Waltenberger J: VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252: 743-746, 1998
37. Liu YX, Christou H, Morita T, Laughner E, Semenza GL, Kourembanas S: Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer. J Biol Chem 273: 15257-15262, 1998